GSK will have a 68% stake in the joint venture, which will bring its Sensodyne, Voltaren and Panadol brands and Pfizer’s Advil, Centrum and Caltrate...
The court dismissed Pfizer’s attempt to prevent generic pregabalin from being used to treat certain types of pain, such as neuropathic pain,...
The legal battle was last seen in the Court of Appeal in 2016, which upheld the previous year’s High Court decision that Pfizer’s patent for...
In November, the Medicines and Healthcare products Regulatory Agency (MHRA) announced that 50mg film-coated sildenafil tablets will be reclassified...
Its decision to approve the reclassification of sildenafil 50mg film-coated tablets – to be manufactured by Pfizer under the brand Viagra Connect –...
Pfizer’s general patent for Lyrica – of which pregabalin is the active ingredient – expired in 2014, but Pfizer retained the product’s patent for the...
Manufacturer Pfizer confirmed on Tuesday (March 28) that it had applied to the Medicines and Healthcare products Regulatory Agency (MHRA) to...
Last month, the government’s fair trade regulator imposed a combined £89.4m fine on the pharmaceutical company Pfizer and the distributor Flynn...
In its provisional findings of an investigation into the “excessive and unfair” pricing, the Competition and Markets Authority (CMA) found the UK...
Last week, the government’s fair trade regulator, the Competition and Markets Authority (CMA), slapped the pharmaceutical companies Pfizer and Flynn...
Download the C+D app today for free on your iOS or Android phone or tablet. Access the latest and most popular news.
SIGN UP FOR OUR NEWSLETTERS
- C+D Daily Bulletin
- • C+D CPD Bulletin
- • C+D Saturday Review
- • C+D Careers Bulletin
- • C+D Briefing Newsletter